| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.COPH.2013.09.005 |
| P698 | PubMed publication ID | 24060699 |
| P50 | author | Tricia Tan | Q60534946 |
| P2093 | author name string | Stephen Bloom | |
| P2860 | cites work | Ghrelin is a growth-hormone-releasing acylated peptide from stomach | Q22010951 |
| P433 | issue | 6 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 996-1001 | |
| P577 | publication date | 2013-09-20 | |
| P1433 | published in | Current Opinion in Pharmacology | Q3007702 |
| P1476 | title | Gut hormones as therapeutic agents in treatment of diabetes and obesity | |
| P478 | volume | 13 |
| Q52590826 | A Narrative Review of Potential Future Antidiabetic Drugs: Should We Expect More? |
| Q34589770 | Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? |
| Q34980692 | Deletion of intestinal epithelial insulin receptor attenuates high-fat diet-induced elevations in cholesterol and stem, enteroendocrine, and Paneth cell mRNAs |
| Q52677504 | Diabetes: Peripheral nerve modulation to treat metabolic disease. |
| Q55315716 | Editorial: Trends in Regulatory Peptides. |
| Q64967272 | Effects of 2 Novel PYY(1-36) Analogues, (P3L31P34)PYY(1-36) and PYY(1-36)(Lys12PAL), on Pancreatic Beta-Cell Function, Growth, and Survival. |
| Q33592515 | Effects of whole grain rye, with and without resistant starch type 2 supplementation, on glucose tolerance, gut hormones, inflammation and appetite regulation in an 11-14.5 hour perspective; a randomized controlled study in healthy subjects |
| Q38667727 | G protein-coupled receptors as new therapeutic targets for type 2 diabetes |
| Q33811125 | Ghrelin Is a Regulator of Glucagon-Like Peptide 1 Secretion and Transcription in Mice |
| Q37424923 | Glucose-Dependent Insulinotropic Polypeptide Ameliorates Mild Traumatic Brain Injury-Induced Cognitive and Sensorimotor Deficits and Neuroinflammation in Rats |
| Q52594233 | Glucose-Dependent Insulinotropic Polypeptide Mitigates 6-OHDA-Induced Behavioral Impairments in Parkinsonian Rats. |
| Q50046451 | Neural circuits of eating behaviour: Opportunities for therapeutic development. |
| Q38583347 | Neuroprotective effects of glucose-dependent insulinotropic polypeptide in Alzheimer's disease |
| Q38730622 | Neurotrophic and neuroprotective effects of oxyntomodulin in neuronal cells and a rat model of stroke |
| Q26866194 | New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases |
| Q38397340 | New perspectives on the development of antiobesity drugs |
| Q42377879 | Single-cell RNA-sequencing reveals a distinct population of proglucagon-expressing cells specific to the mouse upper small intestine |
| Q38375408 | Systematic review and meta-analysis of internal herniation after gastric bypass surgery (Br J Surg 2015; 102: 451-460). |
| Q38527885 | The Place of Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes Therapeutics: A "Me Too" or "the Special One" Antidiabetic Class? |
| Q34468600 | The effects of sleeve gastrectomy on hormonal regulation of glucose metabolism in Goto-Kakizaki rats |
| Q26828382 | The hunger genes: pathways to obesity |
Search more.